Combinatorial treatment of sophoraflavanone G and rhein with ampicillin, oxacillin, or oxytetracycline synergistically increased antibacterial activity against oral bacteria

Daseul Kim, Ki-Young Kim
{"title":"Combinatorial treatment of sophoraflavanone G and rhein with ampicillin, oxacillin, or oxytetracycline synergistically increased antibacterial activity against oral bacteria","authors":"Daseul Kim, Ki-Young Kim","doi":"10.1097/MRM.0000000000000288","DOIUrl":null,"url":null,"abstract":"Various antibacterial agents have been developed to prevent dental diseases but many oral bacteria have been come out with resistance. In this study, antibacterial activities of sophoraflavanone G and rhein were investigated against oral bacteria using the microdilution assay, the checkerboard assay, the growth curve assay, and the disc diffusion assay. Minimum inhibitory concentration(MIC) values of sophoraflavanone G were 1.56 μg/ml against Streptococcus mutans and Fusobacterium nucleatum, 3.125 μg/ml against Streptococcus sobrinus and Actinomyces viscosus, and more than 100 μg/ml against Porphyromonas gingivalis after 24 h treatment, respectively. MIC values of rhein were 100 μg/ml against Strep. mutans and Strep. sobrinus, and 25 μg/ml against A. viscosus, F. nucleatum and Porphyromonas gingivalis after 24 h treatment, respectively. As both of the compounds showed antibacterial activity, combined treatment was accomplished to know synergistic activity between sophoraflavanone G and rhein, and with commercially available antibacterial agents, such as ampicillin, oxacillin, and oxytetracycline. Sophoraflavanone G with rhein showed synergistic antibacterial activity [fractional inhibitory concentration index (FICI) < 0.5] against all tested oral bacteria. Sophoraflavanone G with antibiotics usually showed additive antibacterial activity (0.5 < FICI < 1.0) but interestingly sophoraflavanone G showed strong synergistic activity with ampicillin, which showed resistance against all tested strains, and with oxacillin, which showed resistance against Strep. mutans, and Strep. sobrinus. Even though rhein possessed low antibacterial activity, it showed synergistic activity with ampicillin and oxacillin against drug-resistant strain. These results suggest that sophoraflavanone G and rhein combined with other antibacterial agents may be beneficial and provide the better option to treat the oral bacteria.","PeriodicalId":49625,"journal":{"name":"Reviews in Medical Microbiology","volume":"18 1","pages":"211 - 218"},"PeriodicalIF":0.0000,"publicationDate":"2021-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in Medical Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/MRM.0000000000000288","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

Various antibacterial agents have been developed to prevent dental diseases but many oral bacteria have been come out with resistance. In this study, antibacterial activities of sophoraflavanone G and rhein were investigated against oral bacteria using the microdilution assay, the checkerboard assay, the growth curve assay, and the disc diffusion assay. Minimum inhibitory concentration(MIC) values of sophoraflavanone G were 1.56 μg/ml against Streptococcus mutans and Fusobacterium nucleatum, 3.125 μg/ml against Streptococcus sobrinus and Actinomyces viscosus, and more than 100 μg/ml against Porphyromonas gingivalis after 24 h treatment, respectively. MIC values of rhein were 100 μg/ml against Strep. mutans and Strep. sobrinus, and 25 μg/ml against A. viscosus, F. nucleatum and Porphyromonas gingivalis after 24 h treatment, respectively. As both of the compounds showed antibacterial activity, combined treatment was accomplished to know synergistic activity between sophoraflavanone G and rhein, and with commercially available antibacterial agents, such as ampicillin, oxacillin, and oxytetracycline. Sophoraflavanone G with rhein showed synergistic antibacterial activity [fractional inhibitory concentration index (FICI) < 0.5] against all tested oral bacteria. Sophoraflavanone G with antibiotics usually showed additive antibacterial activity (0.5 < FICI < 1.0) but interestingly sophoraflavanone G showed strong synergistic activity with ampicillin, which showed resistance against all tested strains, and with oxacillin, which showed resistance against Strep. mutans, and Strep. sobrinus. Even though rhein possessed low antibacterial activity, it showed synergistic activity with ampicillin and oxacillin against drug-resistant strain. These results suggest that sophoraflavanone G and rhein combined with other antibacterial agents may be beneficial and provide the better option to treat the oral bacteria.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
槐黄酮G和大黄与氨苄西林、氧西林或土霉素联合治疗可协同增加对口腔细菌的抗菌活性
为了预防口腔疾病,人们开发了各种各样的抗菌剂,但许多口腔细菌却产生了耐药性。采用微量稀释法、棋盘法、生长曲线法和圆盘扩散法研究了苦参黄酮G和大黄酸对口腔细菌的抑菌活性。苦参黄酮G对变形链球菌和核梭杆菌的最小抑制浓度(MIC)分别为1.56 μg/ml,对黑链球菌和粘放线菌的最小抑制浓度(MIC)为3.125 μg/ml,对牙龈卟啉单胞菌的最小抑制浓度(MIC)均大于100 μg/ml。大黄酸对链球菌的MIC值为100 μg/ml。突变体和链球菌。24 h后,分别对粘单胞菌、核单胞菌和牙龈卟啉单胞菌产生25 μg/ml的抑制作用。由于这两种化合物都具有抗菌活性,因此我们完成了联合处理,以了解槐黄酮类化合物G与大黄酸之间以及与市售抗菌剂(如氨苄西林、氧西林和土霉素)的协同活性。槐黄酮G与大黄酸对所有口腔细菌均有协同抑菌作用[分数抑制浓度指数(FICI) < 0.5]。苦参黄酮类化合物G与抗生素通常表现出加性抗菌活性(0.5 < FICI < 1.0),但有趣的是,苦参黄酮类化合物G与氨苄西林具有较强的协同作用,氨苄西林对所有被试菌株都具有耐药性,与恶西林对链球菌具有耐药性。突变体和链球菌。sobrinus。尽管大黄酸具有较低的抗菌活性,但它与氨苄西林和奥西林对耐药菌株具有协同作用。上述结果提示,槐黄酮G和大黄酸与其他抗菌药物联合使用可能是治疗口腔细菌的更好选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Reviews in Medical Microbiology
Reviews in Medical Microbiology 生物-微生物学
CiteScore
1.80
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: Reviews in Medical Microbiology is a quarterly review journal which provides a balanced coverage of the whole field of medical microbiology. The Journal publishes state-of-the art reviews, mini-reviews, case presentations and original research from on-going research of the latest developments and techniques in medical microbiology, virology, mycology, parasitology, clinical microbiology, and hospital infection.​ In addition, PhD-Review - a platform for young researchers, and biographical Bio-Sketch articles are also considered. Reviews are concise, authoritative, and readable synthesis of the latest information on its subject, and references are limited to the fifty key sources for full reviews and twenty for mini-reviews. Reviews in Medical Microbiology is the perfect way for both qualified and trainee microbiologists, and researchers and clinicians with an interest in microbiology, to stay fully informed of the latest developments in medical microbiology. The journal is a valuable resource for educational and teaching purposes.
期刊最新文献
The effectiveness of the immune responses to SARS-CoV-2 Reviews in Medical Microbiology become Reviews and Research in Medical Microbiology A review on antiviral efficacy of Bifidobacterium species Multifunctional dynamic toolbox A case of primary extragenital cutaneous gonorrhea involving the finger
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1